Following the completion of a Phase II trial of sutacimig, Hemab is preparing to progress to a registration trial in 2026.

The global population is ageing and this demographic shift has profound effects on haemostasis, notably a progressive tilt ...

(Family Features) Many people don’t think much about whether their blood is clotting properly. However, when you have a bleeding disorder, a condition that affects the way your body controls clots, it ...

With a $157 million series C funding round, Hemab Therapeutics is looking to infuse innovation into the treatment landscape ...

NATIONAL HARBOR, Md.--(BUSINESS WIRE)--The National Hemophilia Foundation (NHF) has officially changed its name to the National Bleeding Disorders Foundation (NBDF). Foundation leaders announced the ...

Did you know that March is nationally designated as Bleeding Disorders Awareness Month? And recently, Gov. Ayotte signed a proclamation to declare March as Bleeding Disorders Awareness Month in the ...

A one-day CME program titled ‘Bridging the Gap: From Diagnosis to Lifelong Care in Bleeding Disorders’ was successfully held at the Haemophilia Treatment Center, Manipal Academy of Higher Education ...

On Saturday, people with bleeding disorders and their families gathered for a family day and conference at the Pacific ...

INDIANAPOLIS (WISH) — More than 50,000 people are expected to run in the New York City Marathon on Sunday, including an ...

Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Bleeding Disorder Diagnostics Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. Valued at USD 710.26 ...